Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Former FDA Reviewers Says Glaxo Withheld Study
Pharmalot
Monday, July 12, 2010 - 2:35pm
tags:
GSK, Avandia, diabetes, FDA
Gilead Sciences: Undervalued
Seeking Alpha
Monday, July 12, 2010 - 2:34pm
tags:
Gilead Sciences, Merck, JNJ, Vertex Pharmaceuticals
PhRMA not interested in free-sample limits
Fierce Pharma
Monday, July 12, 2010 - 10:54am
tags:
PhRMA, samples, free sample limits, Europe
Biogen says hemophilia drug meets safety goal
Yahoo/AP
Monday, July 12, 2010 - 10:52am
tags:
Biogen Idec, hemophilia, Biovitrum
Kamada: Wise Strategy or Overly Ambitious?
Seeking Alpha
Monday, July 12, 2010 - 10:41am
tags:
Kamada, Talecris, Glassia
Avandia, Qnexa Mean a Big Week for FDA Advisory Committee
WSJ Online
Monday, July 12, 2010 - 10:24am
tags:
Qnexa, Avandia, FDA, GSK, diabetes, obesity, advisory panels, Vivus
Glaxo shares inch higher ahead of FDA meeting
Marketwatch
Monday, July 12, 2010 - 10:21am
tags:
GSK, FDA, Avandia, advisory panels
Sanofi looks to sell EU research sites to Covance
Outsourcing Pharma
Monday, July 12, 2010 - 10:16am
tags:
Sanofi, Covance, Europe
4-Star Stocks Poised to Pop: Abbott Labs
Motley Fool
Monday, July 12, 2010 - 10:15am
tags:
Abbott Laboratories
Three Things To Remember During The Avandia Panel
Forbes
Monday, July 12, 2010 - 10:14am
tags:
GSK, FDA, Avandia, diabetes, advisory panels
J&J to buy Micrus Endovascular for $480 million
Marketwatch
Monday, July 12, 2010 - 10:12am
tags:
Micrus Endovascular, JNJ, M&A
Don't push big pharma off a cliff just yet
Investment News
Sunday, July 11, 2010 - 2:42pm
tags:
Big Pharma, patents, Eli Lilly, Zyprexa, Plavix, Bristol-Myers Squibb, Pfizer, Lipitor, Merck, Singulair
J&J Sued by Consumers Over Children's Cold Medicines
Bloomberg
Sunday, July 11, 2010 - 2:40pm
tags:
JNJ, lawsuits, consumers, recalls
Genentech's New Option for Breast Cancer Patients
Seeking Alpha
Sunday, July 11, 2010 - 2:31pm
tags:
Genentech, breast cancer, Immunogen, Roche, Trastuzumab-Dm1
Trading FDA, Clinical Trial Binary Events: Cumberland Pharma
Seeking Alpha
Sunday, July 11, 2010 - 2:30pm
tags:
FDA, clinical trials, Cumberland
Making the Case for Merck
Seeking Alpha
Sunday, July 11, 2010 - 2:29pm
tags:
Merck
Why Hasn't McNeil's President Resigned Over the Tylenol Recall? (Among Other Unsolved Mysteries at J&J)
BNET Pharma
Sunday, July 11, 2010 - 2:23pm
tags:
JNJ, recalls, Tylenol
India creates an impact in the pharmaceutical industry
Seer Press
Saturday, July 10, 2010 - 11:44am
tags:
India, Sun Pharma, Piramal Healthcare
Will Avandia Be Yanked Off the Market?
US News
Saturday, July 10, 2010 - 11:41am
tags:
Avandia, GSK, diabetes
SPRYCEL® (dasatinib) Receives FDA Priority Review for the Treatment of Adult Patients with Newly Diagnosed Chronic Myeloid Leukemia (CML) in Chronic Phase
Yahoo/BusinessWire
Saturday, July 10, 2010 - 11:39am
tags:
Sprycel, chronic myeloid leukemia, BMS, Otsuka

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.